Evidence map›Paper›PMID 20962430›Full record

ReviewCirculation journal : official journal of the Japanese Circulation Society2010

Cyclophilin A: promising new target in cardiovascular therapy.

Kimio Satoh, Hiroaki Shimokawa, Bradford C Berk

Open access · bronzeAbstract readReview
In one paragraph

Review in Circulation journal : official journal of the Japanese Circulation Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Placental Cyclophilin A Expression in Pregnancies Complicated with Hypertension.International journal of environmental research and public health · 2022
    Article
  7. Article
  8. Article
  9. Peptidyl-prolyl cis-trans isomerase A participates in the selenium transport into the rat brain.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2018
    Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Kimio SatohAab Cardiovascular Research Institute and Department of Medicine, University of Rochester School of Medicine and Dentistry.
Hiroaki Shimokawa
Bradford C Berk
Cardiovascular Institute Hospital · JPTohoku University · JPUniversity of Rochester · US

Funding

Oxidative Stress and Vascular Smoth Muscle Cell GrowthR01HL049192 · NHLBI · UNIVERSITY OF WASHINGTON · PI BERK, BRADFORD C · 1995 to 2019
$6.1M
NHLBI NIH HHS HL49192NHLBI NIH HHS R01 HL049192
6 · The paper itself

Abstract

Cyclophilin A (CyPA) has been studied as a multifunctional protein that is upregulated in a variety of inflammatory conditions, such as rheumatoid arthritis, autoimmune disease, and cancer. CyPA has been classified as an immunophilin and has a variety of intracellular functions, including intracellular signaling, protein trafficking, and the regulation of other proteins activity. Besides its intracellular functions, CyPA is a secreted molecule that has a physiological and pathological role in cardiovascular diseases, making it a potential biomarker and mediator in cardiovascular diseases, such as vascular stenosis, atherosclerosis, and abdominal aortic aneurysms.

Indexed as

AnimalsCardiovascular DiseasesCardiovascular SystemCell ProliferationCyclophilin AEnzyme ActivationHumansMatrix MetalloproteinasesMolecular ChaperonesMuscle, Smooth, VascularOxidative StressReactive Oxygen SpeciesSignal TransductionCyclophilin AMatrix MetalloproteinasesMolecular ChaperonesReactive Oxygen Species

Identifiers

PMID20962430
PMCPMC3052698
OpenAlexW1521146783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.